Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?

Lancet
Juan Pablo GutierrezDavid B Evans

Abstract

The "3 by 5" goal to have 3 million people in low and middle income countries on antiretroviral therapy (ART) by the end of 2005 is ambitious. Estimates of the necessary resources are needed to facilitate resource mobilisation and rapid channelling of funds to where they are required. We estimated the financial costs needed to implement treatment protocols, by use of country-specific estimates for 34 countries that account for 90% of the need for ART in resource-poor settings. We first estimated the number of people needing ART and supporting programmes for each country. We then estimated the cost per patient for each programme by country to derive total costs. We estimate that between US5.1 billion dollars and US5.9 billion dollars will be needed by the end of 2005 to provide ART, support programmes, and cover country-level administrative and logistic costs for 3 by 5.

References

Jun 26, 2001·Science·B SchwartländerS Bertozzi

❮ Previous
Next ❯

Citations

Oct 4, 2005·Nature Reviews. Immunology·Paul NunnMario Raviglione
Aug 2, 2008·AIDS·Susan M ClearyAndrew M Boulle
Oct 15, 2010·AIDS·Ryuichi KomatsuRifat Atun
Jan 27, 2007·AIDS·Sergio Bautista-Arredondo, Stefano M Bertozzi
Nov 12, 2005·BMJ : British Medical Journal·Daniel R HoganJoshua A Salomon
Nov 7, 2007·Cost Effectiveness and Resource Allocation : C/E·Lorna GuinnessKara Hanson
May 31, 2014·PloS One·Taghreed AdamChristopher J L Murray
Dec 4, 2004·PLoS Medicine·Jim Yong Kim, Arthur Ammann
Sep 28, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alok Bhargava
Jun 12, 2010·Current Opinion in HIV and AIDS·Sarah Jane TaleskiAlan Whiteside
Oct 3, 2006·Dermatologic Clinics·Anisa Mosam, Ncoza C Dlova
Sep 24, 2004·Lancet·Roger England
Jun 11, 2015·Future Microbiology·Phiona E NamaleGraeme Meintjes
Nov 19, 2008·Cost Effectiveness and Resource Allocation : C/E·Taghreed AdamDavid B Evans
Dec 7, 2006·Cost Effectiveness and Resource Allocation : C/E·Susan M ClearyAndrew M Boulle
Apr 3, 2008·Expert Review of Anti-infective Therapy·Steven F J CallensRobert Colebunders
Jul 18, 2012·PLoS Medicine·UNKNOWN HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
Aug 7, 2009·Medicine, Conflict, and Survival·Hobokela Stephen, Bayard Roberts
Aug 16, 2018·The International Journal of Health Planning and Management·Marlène Guillon
May 6, 2008·Journal of Midwifery & Women's Health·Suzanne Maman, Elizabeth King
Apr 25, 2006·Cost Effectiveness and Resource Allocation : C/E·Benjamin JohnsDavid B Evans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.